Cargando…
Generation of hypoallergenic neoglycoconjugates for dendritic cell targeted vaccination: A novel tool for specific immunotherapy
The incidence of allergic disorders and asthma continuously increased over the past decades, consuming a considerable proportion of the health care budget. Allergen-specific subcutaneous immunotherapy represents the only intervention treating the underlying causes of type I allergies, but still suff...
Autores principales: | Weinberger, Esther E., Himly, Martin, Myschik, Julia, Hauser, Michael, Altmann, Friedrich, Isakovic, Almedina, Scheiblhofer, Sandra, Thalhamer, Josef, Weiss, Richard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3550522/ https://www.ncbi.nlm.nih.gov/pubmed/23147517 http://dx.doi.org/10.1016/j.jconrel.2012.11.002 |
Ejemplares similares
-
The influence of antigen targeting to sub-cellular compartments on the anti-allergic potential of a DNA vaccine()
por: Weinberger, Esther E., et al.
Publicado: (2013) -
Laser‐facilitated epicutaneous immunotherapy with hypoallergenic beta‐glucan neoglycoconjugates suppresses lung inflammation and avoids local side effects in a mouse model of allergic asthma
por: Korotchenko, Evgeniia, et al.
Publicado: (2020) -
New approaches to transcutaneous immunotherapy: targeting dendritic cells with novel allergen conjugates
por: Weiss, Richard, et al.
Publicado: (2013) -
Transcutaneous delivery of CpG-adjuvanted allergen via laser-generated micropores
por: Hessenberger, Michael, et al.
Publicado: (2013) -
Allergens are not pathogens: Why immunization against allergy differs from vaccination against infectious diseases
por: Weiss, Richard, et al.
Publicado: (2014)